*  Immunologic adjuvant - Wikipedia
The word "adjuvant" comes from the Latin word adiuvare, meaning to help or aid. "An immunologic adjuvant is defined as any ... "Immunologic adjuvants for modern vaccine formulations," F. R. Vogel, Annals of the New York Academy of Sciences, Vol 754, Issue ... ISBN 978-0-89603-580-5. The Use of Conventional Immunologic Adjuvants in DNA Vaccine Preparations, by Shin Sasaki and Kenji ... There are many known adjuvants in widespread use, including oils, aluminium salts, and virosomes. Adjuvants in immunology are ...
  https://en.wikipedia.org/wiki/Immunologic_adjuvant
*  MATRIX: Measuring Neutralizing Antibodies in the Patients Treated With Interferon Beta 1a IM, in Mexico and Colombia - Full...
Immunologic Factors. Physiological Effects of Drugs. Antineoplastic Agents. Antiviral Agents. Anti-Infective Agents. Adjuvants ...
  https://clinicaltrials.gov/ct2/show/NCT01556685
*  Immunogenicity and Safety Study of Serum-Free Avonex - Full Text View - ClinicalTrials.gov
History of any significant cardiac, endocrinologic, hematologic, hepatic, immunologic, metabolic, urologic, pulmonary, ...
  https://clinicaltrials.gov/ct2/show/NCT00912860?term=biogen&spons=biogen&rank=20
*  Evaluating the Safety of and Immune Response to HIV-MAG DNA Vaccine With or Without Plasmid IL-12 Adjuvant Delivered...
Immunologic Factors. Physiological Effects of Drugs. Adjuvants, Immunologic. Angiogenesis Inhibitors. Angiogenesis Modulating ... The HIV-MAG vaccine, IL-12 pDNA adjuvant, and placebos for IL-12 pDNA adjuvant/HIV-MAG vaccines will be delivered IM into the ... The HIV-MAG vaccine, IL-12 pDNA adjuvant, and placebos for IL-12 pDNA adjuvant/HIV-MAG vaccines will be delivered IM into the ... The HIV-MAG vaccine, IL-12 pDNA adjuvant, and placebos for IL-12 pDNA adjuvant/HIV-MAG vaccines will be delivered IM into the ...
  https://clinicaltrials.gov/ct2/show/NCT01578889?term=%22+March+14%2C++2012%22%3A%22+April+13%2C++2012%22%5BFIRST-RECEIVED-DATE%5DAND+HIV%5BCONDITION%5D&rank=8
*  Vaccine Therapy of Prostate Cancer Patients With Recombinant Soluble Prostate-Specific Membrane Antigen (Rs-PSMA) Plus the...
Adjuvants, Immunologic. Immunologic Factors. Physiological Effects of Drugs. Antacids. Molecular Mechanisms of Pharmacological ... Plus the Immunological Adjuvant Alhydrogel. The safety and scientific validity of this study is the responsibility of the study ... Plus the Immunological Adjuvant Alhydrogel: A Trial Studying RsPMSA Doses. ... the safety and tolerability of treatment with increasing dose levels of rsPSMA protein when administered with the adjuvant ...
  https://clinicaltrials.gov/ct2/show/NCT00705835
*  Immunotherapy With Vacc-C5 With Adjuvant GM-CSF or Alhydrogel in HIV-1-infected Subjects on ART - Full Text View -...
Adjuvants, Immunologic. Immunologic Factors. Physiological Effects of Drugs. Antacids. Molecular Mechanisms of Pharmacological ... Immunotherapy With Vacc-C5 With Adjuvant GM-CSF or Alhydrogel in HIV-1-infected Subjects on ART. The safety and scientific ... Arm 1=Arm A: Vacc-C5 with GM-CSF as adjuvant administered intradermally. ... Arm 1=Arm A: Vacc-C5 with GM-CSF as adjuvant administered intradermally. ...
  https://clinicaltrials.gov/ct2/show/NCT01627678?term=%22+June+13%2C++2012%22%3A%22+July+13%2C++2012%22%5BFIRST-RECEIVED-DATE%5DAND+HIV%5BCONDITION%5D&rank=7
*  A Phase I Study of Safety and Immunogenicity of the WRAIR HIV-1 Vaccine - Full Text View - ClinicalTrials.gov
Immunologic Factors. Physiological Effects of Drugs. Adjuvants, Immunologic. Antacids. Molecular Mechanisms of Pharmacological ... LFn-p24 with Alhydrogel adjuvant will be delivered IM in the deltoid muscle at the intervals shown below. Groups will be ... Immunologic Deficiency Syndromes. Immune System Diseases. Vaccines. Aluminum Hydroxide. ...
  https://clinicaltrials.gov/show/NCT00412477?order=113
*  Long Term Extension Study Evaluating Safety, Tolerability And Immunogenicity Of ACC-001 In Japanese Subjects With Mild To...
Active vaccine dose of 3 micrograms +adjuvant, IM injection, at Day 1, month 6, 12 and 18 ... Active vaccine dose of 10 micrograms +adjuvant, IM injection, at Day 1, month 6, 12 and 18 ... Active vaccine dose of 30 micrograms +adjuvant, IM injection, at Day 1, month 6, 12 and 18 ... tolerability and immunogenicity of ACC-001 with QS-21 adjuvant in Japanese subjects with mild to moderate AD who were ...
  https://clinicaltrials.gov/show/NCT01238991
*  Combination Chemotherapy in Treating Patients With AIDS-Related Hodgkin's Disease - Full Text View - ClinicalTrials.gov
Immunologic Factors. Physiological Effects of Drugs. Antirheumatic Agents. Antineoplastic Agents, Alkylating. Alkylating Agents ...
  https://www.clinicaltrials.gov/ct2/show/NCT00003114
*  Topical DHEA Against Vaginal Atrophy - Full Text View - ClinicalTrials.gov
Adjuvants, Immunologic. Immunologic Factors. Physiological Effects of Drugs. To Top. *For Patients and Families ...
  https://clinicaltrials.gov/ct2/show/NCT01846442?term=Porencephaly&rank=10
*  A Double-Blind Placebo Controlled Study To Determine the Optimal Immunopharmacological Dose Level of Isoprinosine in...
Immunologic Deficiency Syndromes. Immune System Diseases. Inosine Pranobex. Adjuvants, Immunologic. Immunologic Factors. ... study is to evaluate the effect of Isoprinosine in a group of homogenous male volunteers who present with immunologic defects ...
  https://clinicaltrials.gov/show/NCT00002059?order=237
*  Evaluating the Safety and Immune Response to an HIV Vaccine Boost Following the Administration of Two HIV Vaccines, in HIV...
Biological: MF59C.1 Adjuvant MF59C.1 adjuvant admixed with 100 mcg of Sub C gp140 vaccine administered as one 0.5 mL injection ... Immunologic Deficiency Syndromes. Immune System Diseases. Vaccines. MF59 oil emulsion. Immunologic Factors. Physiological ... Participants will be randomly assigned to receive either the Sub C gp140 vaccine with MF59 adjuvant or a placebo injection ... 100 mcg of Sub C gp140 vaccine admixed with MF59C.1 adjuvant administered as one 0.5 mL injection intramuscularly (IM) in ...
  https://clinicaltrials.gov/ct2/show/NCT01423825?term=%22+August+10%2C++2011%22%3A%22+September+09%2C++2011%22%5BFIRST-RECEIVED-DATE%5DAND+HIV%5BCONDITION%5D&rank=12
*  S9914: Combination Chemotherapy Plus Filgrastim in Untreated Extensive-Stage Small Cell Lung Cancer - Full Text View -...
Adjuvants, Immunologic. Immunologic Factors. Physiological Effects of Drugs. Topoisomerase I Inhibitors. Topoisomerase ...
  https://clinicaltrials.gov/ct2/show/NCT00004137
*  H5N1 Mix and Match With MF59 - Full Text View - ClinicalTrials.gov
Drug: MF59 Adjuvant Adjuvant/diluent manufactured by Novartis. Biological: H5N1 Antigen Subvirion inactivated monovalent ... Drug: MF59 Adjuvant Adjuvant/diluent manufactured by Novartis. Biological: H5N1 Antigen Subvirion inactivated monovalent ... Drug: MF59 Adjuvant Adjuvant/diluent manufactured by Novartis. Biological: H5N1 Antigen Subvirion inactivated monovalent ... Other: Phosphate Buffered Saline (PBS) diluent Drug: MF59 Adjuvant Biological: H5N1 Antigen Phase 1 ...
  https://clinicaltrials.gov/ct2/show/NCT01317745?term=monovalent+influenza+A%2FH5N1+virus+vaccine+AND+%22louis+university%22&rank=1
*  Safety and Immunogenicity of a Human Hookworm Candidate Vaccine With Different Doses of a Novel Adjuvant - Full Text View -...
Adjuvants, Immunologic. Immunologic Factors. Physiological Effects of Drugs. Antacids. Molecular Mechanisms of Pharmacological ... Safety and Immunogenicity of a Human Hookworm Candidate Vaccine With Different Doses of a Novel Adjuvant. The safety and ... with or without two different dose concentrations of a novel adjuvant, GLA-AF (1 µg or 5 μg) among healthy adult volunteers. ...
  https://clinicaltrials.gov/ct2/show/NCT01385189
*  LEISH-F3 + GLA-SE and the LEISH-F3 + MPL-SE Vaccine - Full Text View - ClinicalTrials.gov
Stable oil-in-water Emulsion (SE) is a squalene oil-in-water emulsion that has adjuvant properties of its own, but in a Th2- ... Investigational products: LEISH-F3 (recombinant protein antigen) + GLA-SE (adjuvant) leishmaniasis vaccine and LEISH-F3 ( ... to yield the adjuvant formulation GLA-SE. The combination of GLA-SE with a recombinant protein antigen (LEISH-F3) results in a ... or SE adjuvant in healthy adults 18 to 49 years of age. Each subject's duration of participation will be about 18 months. ...
  https://clinicaltrials.gov/show/NCT01751048
*  Study of Pre-clearance of Latent Tuberculosis Infection And BCG Revaccination - Full Text View - ClinicalTrials.gov
Blood for immunologic studies will be drawn at study enrollment for subjects, just prior to BCG revaccination, and 1, 2 weeks ... Immunologic outcomes have been chosen with the goal of measuring the characteristics and kinetics of human immune responses ... or any immunologic sampling time point post BCG revaccination. ... Adjuvants, Immunologic. Immunologic Factors. Physiological ...
  https://clinicaltrials.gov/show/NCT01119521?order=134
*  An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease - Full...
Adjuvants, Immunologic. Immunologic Factors. Physiological Effects of Drugs. Antiparkinson Agents. Anti-Dyskinesia Agents. ...
  https://clinicaltrials.gov/show/NCT01096186
*  Neurotropin to Treat Fibromyalgia - Full Text View - ClinicalTrials.gov
Adjuvants, Immunologic. Immunologic Factors. Physiological Effects of Drugs. Analgesics. Sensory System Agents. Peripheral ...
  https://clinicaltrials.gov/ct2/show/NCT00366535?term=fibromyalgia&recr=Open&type=Intr&rank=19